Antonio Villaverde

Antonio Villaverde has been a Professor of Microbiology at the Autonomous University of Barcelona since 2002. He is the leader of the Nanobiotechnology group at the Institute of Biotechnology and Biomedicine and CIBER-BBN, as well as the leader of the consolidated research group in Catalonia on Innovative Biopharmaceuticals. Throughout his scientific career, he has published over 340 scientific articles in indexed journals, has been an author of a similar number of presentations at scientific conferences, and has supervised 25 doctoral theses. In 2002, he founded the journal Microbial Cell Factories, where he served as editor-in-chief for 15 years. He has received three Icrea Academia awards and the Narcís Monturiol Medal for scientific and technological merit. His research interests focus on the development of new nanostructured drugs for various applications, including cancer and regenerative medicine. In 2017, he co-founded the spin-off Nanoligent SL, which has licensed several patent families generated by his research group in recent years.